查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585814

乳房切片市场：按产品类型、指南、应用划分 - 2025-2030 年全球预测

Breast Biopsy Market by Product (Assay Kits, Biopsy Needles, Biopsy Tables), Type (Liquid Breast Biopsy, Needle Breast Biopsy, Open Surgical Breast Biopsy), Guidance, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年乳房切片市场价值为10亿美元，预计2024年将达到10.9亿美元，复合年增长率为9.26%，预计2030年将达到18.7亿美元。

乳房切片市场的范围包括从乳房中取出组织或液体以确定癌细胞是否存在的诊断程序，这对于早期检测和治疗计划至关重要。它广泛用于乳房X光摄影异常或可触及肿块的患者。典型的最终用户包括医院、诊断中心和门诊手术中心。乳癌发病率的上升、早期诊断意识的提高以及对微创手术的需求不断增长正在推动这一需求。影响市场成长的因素包括切片检查仪器的技术进步，例如真空辅助和影像引导方法，这些方法提高了准确性并减少了手术的不适感。乳癌发生率的增加和政府促进早期诊断的措施进一步推动了市场扩张。目前的商机存在于医疗保健基础设施正在改善的新兴市场，为市场渗透提供了肥沃的土壤。公司可以利用人工智慧辅助影像分析和更适合患者的切片检查通讯协定等创新来提高准确性和患者体验。挑战包括高昂的手术成本、患者因手术焦虑而不愿，以及不一致的切片检查结果导致假阳性和假阴性。克服监管障碍是一项额外的挑战，因为任何新技术都必须遵守严格的安全性和有效性标准。为了实现永续成长，公司应专注于开发具有成本效益的解决方案并透过技术进步来提高程序精度。对侵入性较小的技术、改进的成像方式以及将人工智慧整合到预测诊断中的研究可以提供竞争优势。此外，根据个人基因图谱量身定制的个人化乳癌诊断工具是未来创新的一个有前途的领域。市场竞争温和，主要企业不断投资研发以获得竞争优势。促进与医疗保健提供者合作并投资于专业和患者教育的公司可能会占据重要的市场占有率并推动未来的市场动态。

主要市场统计
基准年[2023] 10亿美元
预测年份 [2024] 10.9亿美元
预测年份 [2030] 18.7亿美元
复合年增长率（%） 9.26%

市场动态：快速发展的乳房切片市场的关键市场洞察

供需的动态交互作用正在改变乳房切片市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球乳癌发生率上升
    • 政府提高乳癌意识和治疗的倡议
    • 改变早期乳癌检测和筛检的偏好
  • 市场限制因素
    • 检验高成本且耗时
  • 市场机会
    • 液态切片的出现和有前景的临床试验
    • 增加对乳癌治疗研究和开发的投资和资助
  • 市场挑战
    • 切片穿刺针感染的可能性

波特的五力：驾驭乳房切片市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解乳房切片市场的外部影响

外部宏观环境因素在塑造乳房切片市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解乳房切片市场的竞争格局

乳房切片市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵乳房切片市场供应商的绩效评估

FPNV定位矩阵是评估乳房切片市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了乳房切片市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对乳房切片市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球乳癌发生率正在上升
      • 政府提高乳癌意识和治疗的倡议
      • 改变早期乳癌检测和筛检的偏好
    • 抑制因素
      • 一个昂贵且耗时的过程
    • 机会
      • 液态生物检体的出现和有前景的临床试验
      • 增加对乳癌治疗研究和开发的投资和资助
    • 任务
      • 与切片穿刺针相关的感染的可能性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章乳房切片市场：副产品

  • 检测试剂套件
  • 切片穿刺针
  • 切片检查台
  • 引导系统
  • 液态生物检体仪器
  • 定位线

第七章乳房切片市场：依类型

  • 乳房切片
    • 循环性肿瘤细胞
    • 循环肿瘤DNA
  • 乳房切片
    • 空心针活检
    • 细针抽吸细胞学检查
    • 抽吸辅助切片检查
  • 开放性手术乳房切片
    • 切除
    • 切口

第八章乳房切片市场：依指导

  • 影像引导切片检查
    • 乳房X光摄影引导切片检查定位活检
    • MRI导引切片检查
    • 超音波切片检查
  • 液态生物检体
    • 基于微阵列的切片检查
    • 基于NGS的切片检查
    • 基于PCR的切片检查

第九章乳房切片市场：依应用分类

  • 早期癌症筛检
  • 復发监测
  • 治疗方法选择
  • 治疗监测

第10章美洲乳房切片市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太乳房切片市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的乳房切片市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Quest Diagnostics 收购 Haystack Oncology，将敏感液态生物检体技术添加到其肿瘤产品组合中，以改善个人化癌症治疗
    • Guardant Health 获得 FDA核准Guardant360 CDx 作为美纳里尼集团 ORSERDU 的伴同性诊断，用于治疗 ESR1 突变的 ER+、HER2-进行性或转移性乳癌患者
    • TransMed7 LLC 宣布 SpeedBird乳房切片设备首次临床使用并进行商业性推广
  • 战略分析和建议

公司名单

  • Argon Medical
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc
  • Biocept, Inc.
  • Cook Group Incorporated
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fluxion Biosciences Inc.
  • FUJIFILM Corporation
  • GE HealthCare
  • Guardant Health
  • Halma plc
  • Hologic, Inc.
  • Illumina, Inc.
  • INRAD, Inc.
  • Iskus Health Ltd.
  • Johnson & Johnson Services, Inc.
  • Leica Biosystems Nussloch GmbH
  • Medtronic PLC
  • Merit Medical Systems
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • TransMed7, LLC
  • Trivitron Healthcare
Product Code: MRR-4F4C36263235

The Breast Biopsy Market was valued at USD 1.00 billion in 2023, expected to reach USD 1.09 billion in 2024, and is projected to grow at a CAGR of 9.26%, to USD 1.87 billion by 2030.

The scope of the breast biopsy market encompasses diagnostic procedures to extract tissue or fluid from the breast to determine the presence of cancerous cells, vital for early detection and treatment planning. It widely applies to patients with abnormal mammograms or palpable lumps. The key end-users include hospitals, diagnostic centers, and ambulatory surgical centers. The necessity is driven by rising breast cancer incidences, growing awareness regarding early diagnosis, and increased demand for less invasive procedures. Factors influencing market growth include technological advancements in biopsy instruments such as vacuum-assisted and image-guided methods, which enhance accuracy and reduce procedural discomfort. The increasing incidence of breast cancer and government initiatives promoting early diagnosis further bolster market expansion. Current opportunities lie in emerging markets with improving healthcare infrastructure, offering a fertile ground for market penetration. Businesses could leverage innovations such as AI-assisted image analysis and more patient-friendly biopsy protocols to enhance accuracy and patient experience. Challenges include high procedural costs, patient reluctance due to surgical anxiety, and discrepancies in biopsy results leading to false positives or negatives. Navigating regulatory hurdles poses an additional challenge, as any new technology must comply with stringent safety and efficacy standards. For sustainable growth, firms should focus on developing cost-effective solutions and enhancing procedural accuracy through technological advancements. Research into less invasive techniques, improved imaging modalities, and integrating AI for predictive diagnostics could provide competitive advantages. Moreover, personalized breast cancer diagnosis tools tailored to individual genetic profiles represent a promising area for future innovation. The market is moderately competitive, with key players continuously investing in research and development to gain a competitive edge. Companies that foster collaborations with healthcare providers and invest in educating professionals and patients are likely to capture significant market share and drive future market dynamics.

KEY MARKET STATISTICS
Base Year [2023] USD 1.00 billion
Estimated Year [2024] USD 1.09 billion
Forecast Year [2030] USD 1.87 billion
CAGR (%) 9.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Breast Biopsy Market

The Breast Biopsy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of breast cancer worldwide
    • Government initiative for awareness and treatment of breast cancer
    • Shifting preferences for early detection and screening for breast cancer
  • Market Restraints
    • High-cost and time consuming procedure
  • Market Opportunities
    • Emergence of liquid biopsy and promising clinical trials
    • Increasing investments and funding for R&D of breast cancer treatment
  • Market Challenges
    • Possibilities of infection associated with biopsy needles

Porter's Five Forces: A Strategic Tool for Navigating the Breast Biopsy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Breast Biopsy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Breast Biopsy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Breast Biopsy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Breast Biopsy Market

A detailed market share analysis in the Breast Biopsy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Breast Biopsy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Breast Biopsy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Breast Biopsy Market

A strategic analysis of the Breast Biopsy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Biopsy Market, highlighting leading vendors and their innovative profiles. These include Argon Medical, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc, Biocept, Inc., Cook Group Incorporated, CooperSurgical, Inc., F. Hoffmann-La Roche Ltd., Fluxion Biosciences Inc., FUJIFILM Corporation, GE HealthCare, Guardant Health, Halma plc, Hologic, Inc., Illumina, Inc., INRAD, Inc., Iskus Health Ltd., Johnson & Johnson Services, Inc., Leica Biosystems Nussloch GmbH, Medtronic PLC, Merit Medical Systems, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc., TransMed7, LLC, and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Breast Biopsy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Assay Kits, Biopsy Needles, Biopsy Tables, Guidance Systems, Liquid Biopsy Instruments, and Localization Wires.
  • Based on Type, market is studied across Liquid Breast Biopsy, Needle Breast Biopsy, and Open Surgical Breast Biopsy. The Liquid Breast Biopsy is further studied across Circulating Tumor Cells and Circulating Tumor DNA. The Needle Breast Biopsy is further studied across Core Needle Biopsy, Fine Needle Aspiration Biopsy, and Vacuum-Assisted Biopsy. The Open Surgical Breast Biopsy is further studied across Excisional and Incisional.
  • Based on Guidance, market is studied across Image-Guided Biopsy and Liquid Biopsy. The Image-Guided Biopsy is further studied across Mammography-Guided Stereotactic Biopsy, MRI Guided Biopsy, and Ultrasound-Guided Biopsy. The Liquid Biopsy is further studied across Microarray-Based Biopsy, NGS-Based Biopsy, and PCR-Based Biopsy.
  • Based on Application, market is studied across Early Cancer Screening, Recurrence Monitoring, Therapy Selection, and Treatment Monitoring.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of breast cancer worldwide
      • 5.1.1.2. Government initiative for awareness and treatment of breast cancer
      • 5.1.1.3. Shifting preferences for early detection and screening for breast cancer
    • 5.1.2. Restraints
      • 5.1.2.1. High-cost and time consuming procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of liquid biopsy and promising clinical trials
      • 5.1.3.2. Increasing investments and funding for R&D of breast cancer treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Possibilities of infection associated with biopsy needles
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Breast Biopsy Market, by Product

  • 6.1. Introduction
  • 6.2. Assay Kits
  • 6.3. Biopsy Needles
  • 6.4. Biopsy Tables
  • 6.5. Guidance Systems
  • 6.6. Liquid Biopsy Instruments
  • 6.7. Localization Wires

7. Breast Biopsy Market, by Type

  • 7.1. Introduction
  • 7.2. Liquid Breast Biopsy
    • 7.2.1. Circulating Tumor Cells
    • 7.2.2. Circulating Tumor DNA
  • 7.3. Needle Breast Biopsy
    • 7.3.1. Core Needle Biopsy
    • 7.3.2. Fine Needle Aspiration Biopsy
    • 7.3.3. Vacuum-Assisted Biopsy
  • 7.4. Open Surgical Breast Biopsy
    • 7.4.1. Excisional
    • 7.4.2. Incisional

8. Breast Biopsy Market, by Guidance

  • 8.1. Introduction
  • 8.2. Image-Guided Biopsy
    • 8.2.1. Mammography-Guided Stereotactic Biopsy
    • 8.2.2. MRI Guided Biopsy
    • 8.2.3. Ultrasound-Guided Biopsy
  • 8.3. Liquid Biopsy
    • 8.3.1. Microarray-Based Biopsy
    • 8.3.2. NGS-Based Biopsy
    • 8.3.3. PCR-Based Biopsy

9. Breast Biopsy Market, by Application

  • 9.1. Introduction
  • 9.2. Early Cancer Screening
  • 9.3. Recurrence Monitoring
  • 9.4. Therapy Selection
  • 9.5. Treatment Monitoring

10. Americas Breast Biopsy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Breast Biopsy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Breast Biopsy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
    • 13.3.2. Guardant Health Receives FDA Approval for Guardant360 CDx as Companion Diagnostic for Menarini Group's ORSERDU for the Treatment of Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer
    • 13.3.3. TransMed7, LLC Announces First Clinical Use of SpeedBird Breast Biopsy Devices for Commercial Launch
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Argon Medical
  • 2. Becton, Dickinson, and Company
  • 3. Bio-Rad Laboratories, Inc
  • 4. Biocept, Inc.
  • 5. Cook Group Incorporated
  • 6. CooperSurgical, Inc.
  • 7. F. Hoffmann-La Roche Ltd.
  • 8. Fluxion Biosciences Inc.
  • 9. FUJIFILM Corporation
  • 10. GE HealthCare
  • 11. Guardant Health
  • 12. Halma plc
  • 13. Hologic, Inc.
  • 14. Illumina, Inc.
  • 15. INRAD, Inc.
  • 16. Iskus Health Ltd.
  • 17. Johnson & Johnson Services, Inc.
  • 18. Leica Biosystems Nussloch GmbH
  • 19. Medtronic PLC
  • 20. Merit Medical Systems
  • 21. Siemens Healthineers
  • 22. Sysmex Corporation
  • 23. Thermo Fisher Scientific Inc.
  • 24. TransMed7, LLC
  • 25. Trivitron Healthcare

LIST OF FIGURES

  • FIGURE 1. BREAST BIOPSY MARKET RESEARCH PROCESS
  • FIGURE 2. BREAST BIOPSY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BREAST BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BREAST BIOPSY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BREAST BIOPSY MARKET DYNAMICS
  • TABLE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY TABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY LOCALIZATION WIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY CIRCULATING TUMOR DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BREAST BIOPSY MARKET SIZE, BY EXCISIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BREAST BIOPSY MARKET SIZE, BY INCISIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BREAST BIOPSY MARKET SIZE, BY MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BREAST BIOPSY MARKET SIZE, BY MICROARRAY-BASED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BREAST BIOPSY MARKET SIZE, BY NGS-BASED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BREAST BIOPSY MARKET SIZE, BY PCR-BASED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BREAST BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BREAST BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BREAST BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL BREAST BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 118. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 126. CHINA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 127. CHINA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 135. INDIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 136. INDIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 144. INDONESIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 145. INDONESIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 153. JAPAN BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 154. JAPAN BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 162. MALAYSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 163. MALAYSIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 171. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 172. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 180. SINGAPORE BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 181. SINGAPORE BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 189. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 190. SOUTH KOREA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 198. TAIWAN BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 199. TAIWAN BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 207. THAILAND BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 208. THAILAND BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 216. VIETNAM BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 217. VIETNAM BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 235. DENMARK BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 236. DENMARK BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 244. EGYPT BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 245. EGYPT BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 253. FINLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 254. FINLAND BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 262. FRANCE BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 263. FRANCE BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 271. GERMANY BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 272. GERMANY BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 280. ISRAEL BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 281. ISRAEL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 289. ITALY BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 290. ITALY BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 298. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 299. NETHERLANDS BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 307. NIGERIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 308. NIGERIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 316. NORWAY BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 317. NORWAY BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 325. POLAND BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 326. POLAND BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 334. QATAR BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 335. QATAR BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 336. RUSSIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 337. RUSSIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 343. RUSSIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 344. RUSSIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 345. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 346. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 347. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 348. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 350. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 351. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 352. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY LIQUID BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 353. SAUDI ARABIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 354. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 355. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 356. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 357. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY NEEDLE BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 358. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BREAST BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 359. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY GUIDANCE, 2018-2030 (USD MILLION)
  • TABLE 360. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY IMAGE-GUIDED BIOPSY, 2018-2030 (USD MILLION)
  • TABLE 361. SOUTH AFRICA BREAST BIOPSY MARKET SIZE, BY LIQUID